HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Schachter Selected Research

Lipiderm

3/2001Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Schachter Research Topics

Disease

8Infections
01/2005 - 12/2000
7Melanoma (Melanoma, Malignant)
01/2022 - 02/2000
5Neoplasms (Cancer)
01/2015 - 02/2000
3Trachoma
03/2012 - 01/2001
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2022 - 10/2021
2Disease Progression
01/2017 - 02/2000
2Neoplasm Metastasis (Metastasis)
04/2000 - 02/2000
1Brain Neoplasms (Brain Tumor)
01/2017
1Clinical Deterioration
01/2015
1Vomiting
12/2001
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
12/2001
1Ewing Sarcoma (Sarcoma, Ewing)
06/2001
1Infertility (Sterility)
06/2001
1Dermatitis
03/2001
1Urethritis
05/2000
1Gonorrhea
05/2000
1Breast Neoplasms (Breast Cancer)
02/2000
1Merkel Cell Carcinoma
02/2000

Drug/Important Bio-Agent (IBA)

5Nucleic AcidsIBA
01/2005 - 12/2000
4Ligases (Synthetase)IBA
12/2001 - 05/2000
3pembrolizumabIBA
08/2022 - 10/2021
3Azithromycin (Zithromax)FDA LinkGeneric
03/2012 - 01/2001
2CEACAM1 ProteinIBA
01/2015 - 01/2012
2Anti-Bacterial Agents (Antibiotics)IBA
03/2012 - 01/2001
2DNA (Deoxyribonucleic Acid)IBA
03/2001 - 01/2001
2Pharmaceutical PreparationsIBA
02/2000 - 02/2000
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
1IpilimumabIBA
01/2022
1VemurafenibIBA
01/2017
1Tumor Biomarkers (Tumor Markers)IBA
01/2015
1Melanins (Melanin)IBA
01/2013
1Biomarkers (Surrogate Marker)IBA
01/2012
1Monoclonal AntibodiesIBA
08/2009
1VaccinesIBA
08/2009
1CTLA-4 AntigenIBA
08/2009
1Peptides (Polypeptides)IBA
08/2009
1interleukin-21 (interleukin 21)IBA
08/2009
1Interleukin-2 (IL2)IBA
01/2009
1Membrane Proteins (Integral Membrane Proteins)IBA
12/2001
1Tetracycline (Achromycin)FDA LinkGeneric
12/2001
1Contraceptive Agents (Contraceptives)IBA
12/2001
1IfosfamideFDA LinkGeneric
06/2001
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2001
1Alkylating AgentsIBA
06/2001
1LipidermIBA
03/2001
1BiafineIBA
03/2001
1Ointments (Pastes)IBA
03/2001
1Etoposide (VP 16)FDA LinkGeneric
02/2000
1Topoisomerase II InhibitorsIBA
02/2000
1Biological ProductsIBA
02/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2000
1Paclitaxel (Taxol)FDA LinkGeneric
02/2000

Therapy/Procedure

3Therapeutics
01/2022 - 02/2000
2Immunotherapy
01/2015 - 08/2009
2Lymph Node Excision (Lymph Node Dissection)
04/2000 - 02/2000
1Immunomodulation
08/2009
1Condoms (Condom)
12/2001
1Drug Therapy (Chemotherapy)
02/2000